- Home
- ALLY vs NBIX Comparison
ALLY vs NBIX Comparison
Compare ALLY & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLY
- NBIX
- Stock Information
- Founded
- ALLY 1919
- NBIX 1992
- Country
- ALLY United States
- NBIX United States
- Employees
- ALLY N/A
- NBIX N/A
- Industry
- ALLY Major Banks
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALLY Finance
- NBIX Health Care
- Exchange
- ALLY Nasdaq
- NBIX Nasdaq
- Market Cap
- ALLY 12.0B
- NBIX 13.2B
- IPO Year
- ALLY 2014
- NBIX 1996
- Fundamental
- Price
- ALLY $41.05
- NBIX $139.60
- Analyst Decision
- ALLY Buy
- NBIX Strong Buy
- Analyst Count
- ALLY 18
- NBIX 18
- Target Price
- ALLY $43.47
- NBIX $160.94
- AVG Volume (30 Days)
- ALLY 2.5M
- NBIX 801.6K
- Earning Date
- ALLY 10-17-2025
- NBIX 10-29-2025
- Dividend Yield
- ALLY 2.92%
- NBIX N/A
- EPS Growth
- ALLY N/A
- NBIX 2.97
- EPS
- ALLY 1.04
- NBIX 3.39
- Revenue
- ALLY $6,852,000,000.00
- NBIX $2,509,900,000.00
- Revenue This Year
- ALLY $19.83
- NBIX $20.66
- Revenue Next Year
- ALLY $14.38
- NBIX $14.64
- P/E Ratio
- ALLY $39.48
- NBIX $41.17
- Revenue Growth
- ALLY 1.11
- NBIX 18.42
- 52 Week Low
- ALLY $29.52
- NBIX $84.23
- 52 Week High
- ALLY $43.22
- NBIX $154.61
- Technical
- Relative Strength Index (RSI)
- ALLY 69.38
- NBIX 68.09
- Support Level
- ALLY $37.62
- NBIX $133.62
- Resistance Level
- ALLY $39.20
- NBIX $137.03
- Average True Range (ATR)
- ALLY 0.76
- NBIX 2.36
- MACD
- ALLY 0.32
- NBIX 0.83
- Stochastic Oscillator
- ALLY 89.53
- NBIX 97.44
About ALLY Ally Financial Inc.
Formerly the captive financial arm of General Motors, Ally Financial became an independent publicly traded firm in 2014 and is one of the largest consumer auto lenders in the country. While the firm has expanded its product offerings over time, it remains primarily focused on auto lending, with more than 70% of its loan book in consumer auto loans and dealer financing. Ally also offers auto insurance, commercial loans, credit cards, and holds a portfolio of mortgage debt, giving the bank a diversified business model, which includes brokerage services.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.